Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.3002
Abstract: 3002Background: Hu5F9-G4 (5F9) is a humanized mAb that inhibits CD47, a “don’t eat me” signal for macrophages, and can enhance tumor cell phagocytosis and T-cell priming. Preclinically, 5F9 is acti...
read more here.
Keywords:
class first;
human phase;
phase pharmacokinetic;
first human ... See more keywords